Drausin Wulsin, Immunai’s Director of ML, joins Daniel and Chris to discuss the role of AI in immunotherapy and why it is proving to be the most effective approach to fighting cancer, autoimmune disease, and infectious diseases.
The availability of large amounts of high-dimensional biological data today, combined with advanced machine learning techniques, creates unique opportunities to push the boundaries of what is possible in biology.